Brief: Pentixapharm Holding AG Says Co Discontinues Preclinical Activities To Focus On Clinical Programs
23/10/2025 20:01
Oct 23 (Reuters) - Pentixapharm Holding AG PTPn.DE: PENTIXAPHARM HOLDING AG - DISCONTINUES PRECLINICAL ACTIVITIES TO FOCUS ON CLINICAL PROGRAMS PENTIXAPHARM HOLDING AG: SHARPENED FOCUS INCLUDES AN ADJUSTMENT OF ORGANIZATIONAL STRUCTURE, ACCOMPANIED BY A TARGETED WORKFORCE REDUCTION OF APPROX 50 % PENTIXAPHARM HOLDING AG - ADJUSTMENTS ARE EXPECTED TO LOWER ANNUAL OPERATING COSTS AND EXTEND COMPANY'S CASH RUNWAY THROUGH Q1 OF 2027 Source text: ID:nEQHvnRna Further company coverage: [PTPn.DE] ((Reuters.Briefs@thomsonreuters.com;))